Increase in hypothalamic cholecystokinin following acute and chronic morphine.
Recent evidence supports an antagonistic interaction between cholecystokinin (CCK) and opiate peptides. The present study determined the effects of various levels of morphine treatment on hypothalamic levels of CCK as determined by radioimmunoassay. Acute treatment with morphine sulfate (10 mg/kg) or implantation of one morphine pellet (75 mg free base) increased levels of CCK in whole hypothalamus. Increased exposure to morphine by either chronic injections or implantation of two pellets did not result in a further change in whole hypothalamic CCK levels. In samples dissected into hypothalamic subregions, the effect of morphine on CCK levels was localized to medial but not lateral or posterior regions. These experiments extend earlier in vitro findings and suggest that some of the physiological and behavioral effects of opiate peptides may result from modulation of endogenous CCK.
P L
PL
Faris
M C
MC
Beinfeld
A C
AC
Scallet
J N
JN
Johannessen
J W
JW
Olney
D000818:Animals; D002766:Cholecystokinin / Q000032:analysis*; D007031:Hypothalamus / Q000032:analysis*; D008297:Male; D009020:Morphine / Q000494:pharmacology*; D051381:Rats; D011919:Rats, Inbred Strains; D013997:Time Factors
D009020:Morphine; D002766:Cholecystokinin